Senators ignore Kennedy's gyrations; Trade show dragnet

WASHINGTON - The full Senate will vote on S. 830, legislation that reauthorizes the Prescription Drug User Fee Act (PDUFA) and imposes incremental reforms on the FDA, soon after it returns from the July 4 recess, according to the staff of Senate Majority Leader Trent Lott. An affirmative vote would be an important step toward the first major modernization of drug and biologic regulation in three decades.

The Senate Labor and Human Resources Committee last week ignored the opposition of ranking Democrat Sen. Edward Kennedy (D-Mass.) and completed its outline of

Read the full 902 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE